Shailesh V Shrikhande, Department of Gastrointestinal Surgical Oncology, Tata Memorial Hospital, Mumbai 400012, India.
World J Gastrointest Surg. 2009 Nov 30;1(1):26-9. doi: 10.4240/wjgs.v1.i1.26.
The outcomes for gallbladder cancer remain largely dismal to this day. Overall, the low incidence of gallbladder cancer around the world coupled with an even lower number of patients amenable to surgery at the time of presentation, has precluded the generation of evidence-based guidelines for the management of this cancer. However, while the incidence of the cancer may be decreasing in some parts of the world, in other countries such as India, Japan and Chile, gallbladder cancer continues to affect a sizeable population of patients. As such, there is a growing need to define what constitutes an adequate surgery for each stage of this cancer, based on sound evidence. This editorial provides a broad overview of the existing problems in the management of gallbladder cancer and appeals for multi-institutional studies aimed at answering some of the pertinent questions on the surgical management of gallbladder cancer.
时至今日,胆囊癌的治疗效果仍然不容乐观。总体而言,全球范围内胆囊癌的发病率较低,且在就诊时适合手术的患者数量更少,这使得制定基于循证医学的胆囊癌治疗指南变得不可能。然而,尽管在世界上某些地区,胆囊癌的发病率可能正在下降,但在印度、日本和智利等其他国家,胆囊癌仍在影响着相当一部分患者。因此,基于可靠的证据,越来越有必要为该癌症的每个阶段确定何种手术才是充分的。本社论广泛概述了胆囊癌治疗中存在的问题,并呼吁开展多机构研究,旨在回答一些有关胆囊癌手术治疗的相关问题。